- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00636337
Inattention in Childhood Cancer Survivors (TRICCS)
TRICCS: Targeting Inattention in Childhood Cancer Survivors
Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lymphoblastic leukemia, brain tumors).
Specific Aim 2: To estimate the effect size of this cognitive training program on measures of attention and working memory in survivors of childhood cancer in order to determine whether a larger-scale clinical trial is warranted.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
North Carolina
-
Durham, North Carolina, Forente stater, 27710
- Duke University Medical Center Preston Robert Tisch Brain Tumor Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- A T-score greater than the 75th percentile on either the Cognitive Problems/Inattention or the DSM-IV Inattention subscales of the Conners' Parent Rating Scale
- One or more standard deviations below the mean on the Attention or Working Memory Indices of the WRAML 2 [56] or Attention or Working Memory Indices that are one or more standard deviations below the participant's estimated IQ. These criteria are similar to those used in a trial of methylphenidate with survivors of childhood cancer.
Exclusion Criteria:
- Estimated IQ ≤ 70
- A motor, visual, or auditory handicap that prevents computer use
- A diagnosis of Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, depression, autism, or Pervasive Developmental Disorder
- Insufficient fluency in English. Participants who are currently taking stimulant medications (stable dose for at least 30 days) for attentional difficulties, but who meet inclusion criteria listed below will be allowed to participate.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: 1
Participants meeting inclusion criteria will be provided with a laptop computer outfitted with a wireless card for the duration of the intervention and will be trained in the use of RoboMemo in the clinic by study personnel.
Although many participants may have ready access to home computers, we decided that all participants will be required to use laptops provided by the study for two reasons: 1) to ensure that coaches and participants are blind to treatment condition (as described above), and 2) to ensure that participants will always have access to the intervention program (i.e., they will not compete with other family members for computer time).
Once trained, children will complete the intervention at home.
The intervention will consist of four 30- to 45-minute sessions per week for 8 weeks (total = 32 sessions).
This intervention schedule is similar to the schedule employed by Klingberg and colleagues in their home-based CT trials with ADHD children.
|
Computer program training for attention difficulties.
Andre navn:
|
Placebo komparator: 2
The design will be a double-blind, placebo-controlled trial in which half of the participants will be randomized to the intervention condition and half will receive a comparison computer program.
Specifically, participants assigned to the comparison (placebo) condition will complete a modified version of the CT at home.
The treatment and comparison CT programs begin identically, at the lowest difficulty level.
Those in the treatment condition will complete activities of increasing difficulty over the intervention period.
Those in the placebo condition, in contrast, will complete the same basic tasks during each session of the intervention, regardless of performance.
In this way, a true estimate can be obtained of the efficacy of the treatment program.
|
Comparison computer program
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Memory
Tidsramme: 2 months and 3 months
|
2 months and 3 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Feasibility
Tidsramme: once a month for 3 months
|
once a month for 3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Kristi Hardy, PhD, Duke University
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- Pro00003249
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Barnekreft
-
Hospices Civils de LyonHar ikke rekruttert ennåEarly Childhood Caries (ECC)Frankrike
-
National Cancer Institute (NCI)FullførtUbehandlet barnehjernestammegliom | Ubehandlet Childhood Anaplastic Astrocytoma | Ubehandlet Childhood Anaplastic Oligodendroglioma | Ubehandlet gigantcelleglioblastom i barndommen | Ubehandlet glioblastom i barndommen | Ubehandlet Childhood Gliomatosis Cerebri | Ubehandlet Childhood Gliosarcoma | Ubehandlet...Forente stater
-
Children's Oncology GroupNational Cancer Institute (NCI)FullførtChildhood Infratentorial Ependymoma | Supratentorial ependymom i barndommen | Nylig diagnostisert Childhood EpendymomaForente stater
-
Institut National de la Santé Et de la Recherche...FullførtAlternerende Hemiplegia of ChildhoodFrankrike
-
University of UtahJazz Pharmaceuticals; Alternating Hemiplegia of Childhood FoundationFullførtAlternerende Hemiplegia of ChildhoodForente stater
-
Assistance Publique - Hôpitaux de ParisHar ikke rekruttert ennåAlternerende Hemiplegia of ChildhoodFrankrike
-
University Hospital, BrestRekrutteringPsykotisk lidelse | Psykose av Childhood BorderlineFrankrike
-
Children's Oncology GroupNational Cancer Institute (NCI)FullførtStage I Childhood Hodgkin-lymfom | Fase II Hodgkin-lymfom hos barn | Utarming av lymfocytter i barndommen Hodgkin-lymfom | Childhood Mixed Cellularity Hodgkin-lymfom | Nodulær sklerose i barndommen Hodgkin lymfom | Barndommens gunstige prognose Hodgkin lymfomForente stater
-
National Cancer Institute (NCI)FullførtGlioblastom | Gliosarkom | Anaplastisk astrocytom | Ubehandlet barnehjernestammegliom | Kjempecelleglioblastom | Ubehandlet Childhood Anaplastic Astrocytoma | Ubehandlet gigantcelleglioblastom i barndommen | Ubehandlet glioblastom i barndommen | Ubehandlet Childhood Gliosarcoma | Hjernestamgliom | Ubehandlet... og andre forholdForente stater
-
Hospices Civils de LyonFullført
Kliniske studier på Attention Training
-
University of MiamiUnited States Department of DefensePåmelding etter invitasjon
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Fullført
-
Children's Hospital Medical Center, CincinnatiFullførtAttention Deficit Hyperactivity DisorderForente stater
-
King's College LondonAktiv, ikke rekrutterendeOverstadig spiseforstyrrelseStorbritannia
-
Pietro IaffaldanoFullførtADHD Overveiende uoppmerksom type | Multippel sklerose i pediatrisk begynnelse
-
Queens College, The City University of New YorkFullførtAttention Deficit Hyperactivity DisorderForente stater
-
Tel Aviv UniversityFullført
-
Ministry of Science and Technology, TaiwanFullførtMild kognitiv svikt
-
Tel Aviv UniversityFullført
-
University of PittsburghNational Cancer Institute (NCI); National Institutes of Health (NIH)Rekruttering